Recorded Chinese product: 舒肝宁注射液舒肝宁注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 贵州瑞和制药有限公司Chinese legal name: 贵州瑞和制药有限公司
主要成分Active Ingredients
- 茵陈提取物Yinchen Tiqu Wu
- 栀子提取物Zhizi Tiqu Wu
- 黄芩苷Huangqin Gan
- 板蓝根提取物Banlan Genti Quwu
- 灵芝提取物Lingzhi Tiqu Wu
药物知识说明
茵陈提取物是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括:栀子提取物、黄芩苷Huangqin Gan。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品:栀子提取物-e1a82b81成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 舒肝宁注射液) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 黄芩苷Huangqin Gan.
Explore other medicines containing the same ingredient: 栀子提取物 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 舒肝宁注射液Recorded Chinese product: 舒肝宁注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 每支装2ml,10ml,20ml2 mL per unit, 10 mL, 20 mL
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 贵州瑞和制药有限公司Chinese legal name: 贵州瑞和制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z20025660
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z20025660
Manufacturer
Chinese legal name: 贵州瑞和制药有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字Z20025660
生产企业
贵州瑞和制药有限公司(国产)
功能主治
清热解毒,利湿退黄,益气扶正,保肝护肝。用于湿热黄疸,症见面目俱黄,胸肋胀满,恶心呕吐,小便黄赤,乏力,纳差,便溏;急、慢性病毒性肝炎见前述症状者。
用法用量
静脉滴注,一次10-20ml,用l0%葡萄糖注射液250-500ml稀释后静脉滴注,一日1次;症状缓解后可改用肌内注射,一日2-4ml;一日1次。
不良反应
偶见,以各种类型过敏反应为主,其中一般过敏反应可见皮疹、皮肤瘙痒、发热、面红等。严重过敏反应可见过敏性休克等。
禁忌
对本品过敏者禁用。
注意事项
1.用药前仔细询问患者过敏史,过敏体质者及孕妇慎用。 |2.注射前严密观察药液性状,有浑浊、沉淀、絮状物或瓶身细微破裂时严禁使用。 |3.严禁与其它药物混合配伍使用。谨慎联合用药。 |4.特殊人群,如过敏体质者、老年人、体弱者、儿童、危重病人等患者应慎重使用,加强监测。 |5.用药过程中,应密切观察用药反应,尤其在用药的30分钟内,如出现异常应及时停药并采取相应的处理措施。 |6.严格按规定用法用量用药。 |7.使用时滴注速度不宜过快,儿童以10~20滴/分,成年以40~60滴/分为宜。
贮藏
密封,避光。
规格
每支装2ml,10ml,20ml
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.